Aduro Biotech (NASDAQ:ADRO)

Aduro Biotech (NASDAQ:ADRO)


Share Price
$ 1.33
Change
-0.09 (-6.34 %)
Market Cap
$106.46 m
Proactive Investors - Run By Investors For Investors

Aduro Biotech

Aduro is dedicated to its mission to discover, develop, and commercialize immunotherapies that transform the treatment of challenging diseases, including cancer.

To fulfill its mission, the company is advancing several leading-edge proprietary technologies that are designed to initiate and sustain the immune system to mobilize and attack tumors. Collectively, Aduro’s technologies are...

EPIC: ADRO
Market: NASDAQ:ADRO
52-week High/Low: $8.100 / $1.320
Sector: Pharmaceuticals
Market Cap: $106.46 m
Website: www.aduro.com
col 3
col 4
col 5
col 6

Aduro Biotech Timeline

Video RSS

Videos

VIEW ALL VIDEOS

© Proactive Investors 2019

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use